All Industries

Top Life Sciences Companies

372 Life Sciences companies, sorted by total funding raised.

Vir BiotechnologyIPO

Clinical-stage biotech developing antibody- and T-cell engager-based therapeutics for infectious ...

San Francisco, United States201–500Biotech, Drug Discovery
Growth Equity·$250.0M·Oct 2024
InventisBioIPO

Clinical-stage biopharmaceutical company developing small-molecule therapies for oncology, autoim...

Shanghai, China11–50Biotech, Life Sciences
Series D·$247.0M·Sep 2020
Agios PharmaceuticalsIPO

Commercial-stage biopharmaceutical company developing therapies for rare hematologic diseases by ...

Cambridge, United States501–1000Biotech, Healthcare
Series C·$241.0M·Nov 2011
Elligo Health Research

Connecting life sciences companies with physicians, patients, and data to accelerate clinical tri...

Austin, United States201–500Biotech, Healthcare
Series E·$236.0M·Sep 2021
Harbor Health

Austin-based primary and specialty clinic group that provides integrated care and clinician-desig...

Austin, United States201–500Life Sciences, Healthcare
Series C·$225.5M·Sep 2025
PB Health

PB Health is a comprehensive healthcare delivery platform comprising network of hospitals, preven...

Gurugram, India51–200Life Sciences, Healthcare
Seed·$218.0M·May 2025
PharvarisIPO

Pharvaris is a clinical-stage company focused on the discovery and development of treatments for ...

Zug, Switzerland51–200Life Sciences, Biotech
Private Equity·$216.0M·Jun 2023
DP Technology

Develops AI-for-Science platforms and tools to accelerate scientific discovery for researchers an...

Beijing, China201–500Computational Biology, Drug Discovery
Series C·$213.7M·Dec 2025
FibroGenIPO

Develops novel therapeutics in oncology and anemia, advancing antibody-drug conjugates and HIF-PH...

San Francisco, United States11–50Biotech, Life Sciences
Series F·$211.5M·Nov 2014
Autobahn Therapeutics

Autobahn Therapeutics is a biotechnology company developing a portfolio of neuropsychiatric and n...

San Diego, United States11–50Life Sciences
Series C·$208.7M·Jul 2024
Truvian

Develops an automated benchtop blood-testing analyzer that delivers lab-accurate routine blood te...

San Diego, United States51–200Life Sciences, Diagnostics
Growth Equity·$206.1M·Jul 2024
Chai Discovery

Chai Discovery builds frontier AI to predict and reprogram interactions between biochemical molec...

San Francisco, United States11–50Artificial Intelligence, Biotech
Venture Unknown·$200.0M·Dec 2025
HarmonyCares

Provides physician-led, value-based in-home primary care and ancillary services for medically com...

Troy, United States1001–5000Life Sciences, Healthcare
Growth Equity·$200.0M·Jul 2024
SeLux Diagnostics, Inc.

R&D company with 4 SBIR/STTR awards from Department of Health and Human Services.

Charlestown, United States1–10Healthcare, Life Sciences
Venture Unknown·$197.3M·Apr 2024
SchrödingerIPO

Physics-based computational platform for molecular design that helps pharmaceutical, biotechnolog...

New York, United States501–1000Artificial Intelligence, Biotech
Series E·$195.0M·May 2019
Cellanome

Biotechnology company developing an automated platform for multimodal single-cell analysis, enabl...

Foster City, United States51–200Biotech, Lab Equipment
Series B·$192.8M·Jan 2024
Fabric

Fabric is a healthcare technology company offering an AI-powered care enablement platform that un...

New York, United States201–500Artificial Intelligence, Healthcare
Series A·$190.0M·Feb 2024
TScan TherapeuticsIPO

Clinical-stage biotechnology company developing T cell receptor (TCR)-engineered T cell therapies...

Waltham, United States51–200Biotech, Healthcare
Corporate Round·$190.0M·Dec 2024
A
Apprentice

AI-native manufacturing execution platform for life science and pharma manufacturing teams.

New York City, United States51–200Life Sciences, Manufacturing Software
Series D·$189.0M·Jan 2024
CANbridge

CANbridge is a biotechnology company focused on developing and commercializing rare disease thera...

Burlington, China201–500Life Sciences, Biotech
Series E·$186.0M·Dec 2020
Watershed Informatics

Cloud platform for omics data analysis and collaboration, serving biopharma and research teams to...

Cambridge, United States11–50Bioinformatics, Healthcare
Series C·$184.5M·Feb 2024
Caribou BiosciencesIPO

Clinical-stage biopharmaceutical company developing genome-edited allogeneic CAR-T cell therapies...

Berkeley, United States51–200Biotech, Life Sciences
Corporate Round·$181.0M·Jul 2023
AdageneIPO

Adagene is a clinical-stage biotechnology company focused on developing innovative antibodies wit...

Suzhou, China51–200Life Sciences, Artificial Intelligence
Corporate Round·$180.0M·Jul 2025
VectorY

VectorY is on a mission to provide patients with neurodegenerative diseases a longer, better life...

Amsterdam, Netherlands51–200Life Sciences
Series A·$175.6M·Nov 2023
Ironwood PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing therapies for gastrointestinal diseases ...

Boston, United States201–500Biotech, Healthcare
Corporate Round·$175.0M·Feb 2019